VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
INO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
INOInovio Pharmaceuticals, Inc.
$1.22$100M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksINOQuarterly Balance Sheet

Inovio Pharmaceuticals, Inc. (INO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Inovio Pharmaceuticals, Inc. (INO) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

INO Balance Sheet

Quarterly statement

INO Balance Sheet

Inovio Pharmaceuticals, Inc. (INO) balance sheet — 27-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets39.91M39.44M61.12M55.18M52.7M71.89M97.83M91.28M117.56M111.68M153.11M174.77M203.28M233.9M315.24M350.21M416.19M399.91M448.44M487.4M
Cash & Short-Term Investments36.67M37.68M58.51M50.8M47.55M68.36M94.11M84.8M110.42M105.61M145.29M167.47M194.93M223.75M253M281.88M348.13M360.39M401.31M394.94M
Cash Only31.53M26.27M44.27M36.57M24.35M39.92M65.81M21.69M34.39M19.6M14.31M18.8M52.71M28.24M46.33M21.99M41.1M59.01M71.14M67.94M
Short-Term Investments5.15M11.41M14.24M14.24M23.2M28.45M28.3M63.12M76.03M86.01M130.98M148.67M142.21M195.51M206.67M259.89M307.02M301.38M330.17M327M
Accounts Receivable00450978.59K840.31K1.31M1.2M1.86M1.77M2.55M2.41M2.14M5.12M5.04M11.74M10.08M11.37M7.49M8.03M7.13M
Days Sales Outstanding-----1.73K1.2K-1.95K-2.04K859.752.04K6.57K8.05K107.81.09K3.51K830.913.31K
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets000000000020.43K34.92K11.93K195.85K30.38M000261.19K0
Total Non-Current Assets9.48M10.34M13.19M14.21M15.54M15.38M15.37M15.78M16.24M17.43M17.84M18.33M29.75M32.69M33.29M41.76M43.21M45.6M47.5M48.37M
Property, Plant & Equipment7.56M8.33M9.07M9.7M10.45M11.09M11.77M12.56M13.33M14.17M14.45M14.73M15.79M16.85M17.96M26.17M27.13M27.95M29.02M29.46M
Fixed Asset Turnover-----0.01x0.01x-0.01x-0.01x0.03x0.01x0.01x0.01x0.34x0.03x0.01x0.03x0.01x
Goodwill00000000000010.51M10.51M10.51M10.51M10.51M10.51M10.51M10.51M
Intangible Assets00000000000002.05M2.13M2.25M2.37M2.5M2.63M2.75M
Long-Term Investments002.1M2.5M3.09M2.31M1.61M2.64M2.32M2.65M2.78M2.99M2.78M2.62M2.01M2.13M2.44M3.37M3.91M3.89M
Other Non-Current Assets1.92M2.01M2.01M2.01M2.01M1.98M1.98M566.41K585.91K605.32K605.32K605.32K666.89K652.52K684.04K701.99K770.14K1.27M1.43M1.76M
Total Assets49.39M49.78M74.31M69.39M68.24M87.27M113.2M107.06M133.8M129.11M170.95M193.1M233.04M266.58M348.53M391.97M459.4M445.51M495.94M535.76M
Asset Turnover-----0.00x0.00x-0.00x-0.00x0.00x0.00x0.00x0.00x0.02x0.00x0.00x0.00x0.00x
Asset Growth %-27.62%-42.96%-34.35%-35.19%-49%-32.41%-33.78%-44.56%-42.59%-51.57%-50.95%-50.74%-49.27%-40.16%-29.72%-26.84%-22.38%-31.97%-8.12%22.37%
Total Current Liabilities39.92M37.92M43.67M69.82M31.71M27.33M35.33M23.5M26.4M23.4M42.57M43.71M51.93M55.15M96.87M94.91M131.06M59.36M65.74M51.38M
Accounts Payable11.65M1.99M2.62M5.9M5.48M5.52M6.44M5.39M6.41M8.3M4.65M3.9M10.36M12.61M21.08M14.27M39.57M39.52M27.97M29.15M
Days Payables Outstanding-278.12519.9-675.3-701.31-807.51-2.25K--1.32K1.21K---1.91K-
Short-Term Debt0002.74M00000016.77M16.49M16.71M16.39M000000
Deferred Revenue (Current)00000000000000008.98M15.38K21.63K77.88K
Other Current Liabilities25.02M27.02M36.44M52.44M20.08M15.86M23.26M9.92M8.66M5.71M9.95M14.04M12.52M11.82M15.14M16.78M18.01M5.32M20.71M6M
Current Ratio1.00x1.04x1.40x0.79x1.66x2.63x2.77x3.88x4.45x4.77x3.60x4.00x3.91x4.24x3.25x3.69x3.18x6.74x6.82x9.49x
Quick Ratio1.00x1.04x1.40x0.79x1.66x2.63x2.77x3.88x4.45x4.77x3.60x4.00x3.91x4.24x3.25x3.69x3.18x6.74x6.82x9.49x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities5.1M5.79M6.55M7.28M8M8.7M9.37M10.02M10.66M11.27M11.03M11.23M11.73M12.22M29.3M30.36M30.66M31.07M30.53M30.81M
Long-Term Debt0000000000000016.61M16.3M16.52M16.21M14.96M14.48M
Capital Lease Obligations5.1M5.79M6.55M7.28M8M8.7M9.37M10.02M10.66M11.27M11.03M11.19M11.7M12.19M12.66M13.31M14.05M14.77M15.46M16.13M
Deferred Tax Liabilities0000000000032.05K32.05K32.05K32.05K32.05K32.05K32.05K32.05K32.05K
Other Non-Current Liabilities000000000000000710.35K0014.83K101.64K
Total Liabilities45.02M43.71M50.21M77.11M39.71M36.02M44.69M33.52M37.06M34.67M53.6M54.94M63.67M67.37M126.17M125.27M161.73M90.43M96.27M82.19M
Total Debt8M8.7M9.37M10.02M10.66M11.27M11.87M12.45M12.98M13.43M30.21M29.8M30.76M31.16M32.07M32.43M33.31M33.65M33.02M33.15M
Net Debt-23.52M-17.58M-34.91M-26.55M-13.69M-28.64M-53.95M-9.24M-21.41M-6.18M15.9M11M-21.95M2.92M-14.25M10.45M-7.79M-25.36M-38.12M-34.79M
Debt / Equity1.83x1.43x0.39x-0.37x0.22x0.17x0.17x0.13x0.14x0.26x0.22x0.18x0.16x0.14x0.12x0.11x0.09x0.08x0.07x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage----------170.34x-87.56x-107.23x-112.35x-128.67x-172.73x-119.53x-345.10x-244.33x-221.66x-125.31x
Total Equity4.37M6.07M24.1M-7.72M28.53M51.25M68.5M73.54M96.74M94.44M117.35M138.16M169.37M199.21M222.36M266.7M297.67M355.09M399.67M453.57M
Equity Growth %-84.68%-88.16%-64.82%-110.5%-70.51%-45.73%-41.62%-46.77%-42.88%-52.59%-47.23%-48.2%-43.1%-43.9%-44.36%-41.2%-41.47%-38.95%-13.33%39.99%
Book Value per Share0.050.090.35-0.150.731.332.112.613.564.055.156.177.699.2510.401.071.271.621.902.16
Total Shareholders' Equity4.37M6.07M24.1M-7.72M28.53M51.25M68.5M73.54M96.74M94.44M117.35M138.16M169.37M199.21M222.36M266.7M297.67M355.09M399.67M453.57M
Common Stock82.34K69.77K69K53.57K36.72K36.67K36.1K26.05K25.96K23.37K22.79K269.73K268.07K262.74K21.09K249.48K247.5K226.51K217.38K210.36K
Retained Earnings-1.84B-1.83B-1.82B-1.82B-1.77B-1.75B-1.73B-1.71B-1.69B-1.65B-1.62B-1.6B-1.56B-1.53B-1.49B-1.43B-1.4B-1.29B-1.21B-1.1B
Treasury Stock00000000000000000000
Accumulated OCI-279.98K-636.09K-637.96K-647.36K-661.74K-661.32K-675.67K-623.46K-689.54K-676.21K-662.6K-751.07K-691.26K-582.8K-698.74K-885.21K-649.66K-457.89K-282.24K-257.93K
Minority Interest00000000000000000000